PCR tests1in 3Q23 vs.3.9 million in 3Q22Gross margin negatively impacted in 3Q by fewer COVID-19 vaccinations and PCR tests,reimbursement pressure net 53、of procurement savings,and brand mix impactsGross profit increased year over year excluding COVID-191.COVID-19 PCR tests are excluded ...
Let me now walk you through the assumptions and guidance for each of our reporting segments, starting with US Retail Pharmacy. Sales are projected to decline low single digit. A lower sales contribution from vaccinations and testing will reduce the growth by 2 percentage points whereas the low m...